Franco M. Muggia, MD

Professor of Medicine, New York University School of Medicine, New York, NY, USA

Dr. Muggia was a senior investigator at the National Cancer Institute from 1969 to 1972, and also Associate Director for the Cancer Therapy Evaluation Program at NCI from 1975 to 1979, during which time he was responsible for the clinical development of cisplatin. He subsequently headed Medical Oncology at New York University (1979-1986; 1996-2009) and the University of Southern California Comprehensive Cancer Center (1986-1996), while also serving as Associate Director for Clinical Investigations at these institutions, and Director of the NYU Kaplan Cancer Center (1997-9). He has led the combined fellowship training program in Hematology/Oncology at New York University Cancer Institute (2006-2010). Other positions and honors include the following: Principal Investigator of a Bristol Myers Squibb Foundation Award to the University of Southern California; Chairman of the Medical Oncology Committee of the Gynecology Oncology Group; Chairman and Medical Director of the Chemotherapy Foundation; member of the executive committee of the Scientific Advisory Board of the American Italian Foundation for Cancer Research, and of the Lynne Cohen Foundation for Ovarian Cancer Research. Also he has co-led international symposia: on Platinum Coordination Compounds in Cancer (2003), and on Hereditary Breast and Ovarian Cancers (2009, 2011). He has authored numerous scientific articles, books, and book chapters. His present interests include: development of anticancer drugs, intraperitoneal therapy for gynecologic and gastrointestinal cancers, and early identification and prevention of cancers in women at high-risk.